Prostate cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1 Biochemical failure of a cT1~3bN0~1M0, radical prostatectomy +/- pelvic lymph node dissection. 2 Adenocarcinoma or Tubular adenocarcinoma 3 Performance status0-1 4 I cannot detect a macroscopic lesion in an examination for image at the time of a recurrence diagnosis 5 The thing that is obtained a document agreement by a patient on participating of this study
Exclusion criteria
Exclusion criteria: 1.Prior exposure to any anti-cancer drug and/or hormonal agents. 2.History of pelvic irradiation. 3.Active overlap cancer 4.I have various disorders to impair inspection, treatment 5.In addition, the patient who was judged to be inappropriate as an object by the judgment of the doctor
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 5-year biochemical disease-free survival rate | — |
Secondary
| Measure | Time frame |
|---|---|
| Five years overall survival rate Clinical recurrence style The immediate nature period and close intestinal tract/urinary tract toxicity incidence | — |
Countries
Japan
Contacts
Kamagaya General Hospital Radiation therapy